| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/28/2002 | WO2002016317A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016315A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/28/2002 | WO2002016314A1 Substituted polyamine compounds |
| 02/28/2002 | WO2002016311A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 02/28/2002 | WO2002015884A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2001076530A3 Il-8 receptor antagonists |
| 02/28/2002 | WO2001068600A3 Benzylated pde4 inhibitors |
| 02/28/2002 | WO2001066524A3 Intermediates useful for the synthesis of huperzine a |
| 02/28/2002 | WO2001042216A3 Caspase inhibitors and uses thereof |
| 02/28/2002 | WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/28/2002 | US20020026060 RAR selective retinoid agonists |
| 02/28/2002 | US20020026055 Aminopyridine-containing thiourea inhibitors of herpes viruses |
| 02/28/2002 | US20020025947 Serine protease inhibitor |
| 02/28/2002 | CA2419592A1 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | CA2415842A1 Process for the preparation of 2-aminoethylpyridines |
| 02/28/2002 | CA2415838A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/27/2002 | EP1182197A1 Single step preparation of ionic fluids |
| 02/27/2002 | EP1182196A1 Halogenide-free preparation of ionic fluids |
| 02/27/2002 | EP1182183A1 Anthracene derivatives and organic electroluminescent devices made by using the same |
| 02/27/2002 | EP1181932A2 Therapeutic compositions comprising excess enantiomer of amlodipine |
| 02/27/2002 | EP1181281A2 Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists |
| 02/27/2002 | EP1181280A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides |
| 02/27/2002 | EP1181271A2 Naphthalene ureas as glucose uptake enhancers |
| 02/27/2002 | EP1181269A1 Cell proliferation inhibitors |
| 02/27/2002 | EP1181267A1 Halogen compounds |
| 02/27/2002 | EP1181266A1 Squaric acid derivatives as cell adhesion molecules |
| 02/27/2002 | EP0971907B1 Method for producing 1,3-di-substituted 2-nitroguanidines |
| 02/27/2002 | EP0946609B1 Polymerization of ethylene with specific iron or cobalt complexes, novel pyridinebis(imines) and novel complexes of pyridinebis(imines) with iron and cobalt |
| 02/27/2002 | EP0945434B1 Process for producing halogenated heteroaryl compounds |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337949A Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid as TACE inhibitor |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1337941A Amide derivatives |
| 02/27/2002 | CN1079794C Ether compound, use thereof, and intermediate for producing the compound |
| 02/27/2002 | CN1079789C Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same |
| 02/26/2002 | US6350907 Matrix metalloprotease inhibitors |
| 02/26/2002 | US6350876 4-chloro-3,5-dimethyl-2-sulfonyl pyridines |
| 02/26/2002 | US6350764 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 02/26/2002 | US6350746 Benzamidine derivatives and their use as anti-coagulants |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/26/2002 | CA2143249C Substituted sulfonamides; process for preparing the same and pharmaceutical compositions containing them |
| 02/21/2002 | WO2002014311A2 Urea compounds and methods of uses |
| 02/21/2002 | WO2002014282A1 2-aminopyridine compounds and use thereof as drugs |
| 02/21/2002 | WO2002014281A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | WO2002014272A1 (thio)urea derivatives, process for their production and medicines containing the derivatives |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002014265A1 Novel 3-substituted urea derivatives and medicinal use thereof |
| 02/21/2002 | WO2002014262A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | WO2002014261A2 4-substituted d-glutamic acid derivatives for use as antibiotic |
| 02/21/2002 | WO2002014259A1 Calcium receptor antagonists |
| 02/21/2002 | WO2002014244A1 Hydrocarbon compound, material for organic electroluminescent element and organic electroluminescent element |
| 02/21/2002 | WO2002013823A1 Micronized torsemide |
| 02/21/2002 | WO2001072291A3 Treatment of movement disorders with metabotropic glutamate receptor antagonist |
| 02/21/2002 | WO2001060820A3 Matrix metalloproteinase inhibitors and uses thereof |
| 02/21/2002 | WO2001055175A3 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 02/21/2002 | WO2001046110A3 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 02/21/2002 | US20020022647 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
| 02/21/2002 | US20020022643 1,1- and 1,2-disubstituted cyclopropane compounds |
| 02/21/2002 | US20020022642 As nitric oxide synthase (NOS) inhibitors, used in therapy and prophylaxis of central nervous system disorders, inflammatory disorders, septic shock and other disorders |
| 02/21/2002 | US20020022638 For therapy and prophylaxis of metabolic disorders related to insulin resistance or hyperglycemia, atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension and frequent urination |
| 02/21/2002 | US20020022628 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 02/21/2002 | US20020022614 Thrombin or factor Xa inhibitors |
| 02/21/2002 | US20020022596 Novel malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them |
| 02/21/2002 | CA2419081A1 Micronized torsemide |
| 02/21/2002 | CA2419008A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/20/2002 | EP1180514A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 02/20/2002 | EP1180512A1 Fungicidal phenylimine derivatives |
| 02/20/2002 | EP1180100A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/20/2002 | EP1180099A1 New compounds |
| 02/20/2002 | EP1180098A1 New compounds |
| 02/20/2002 | CN1336918A Substituted 2-phenylpyridines as herbicides |
| 02/20/2002 | CN1336917A Amide compounds |
| 02/20/2002 | CN1336912A Novel propargylether derivatives |
| 02/20/2002 | CN1336356A Method for prepn. of alkaline organic nitrogen-contg. compound by using aluminium lithium oxide reduction method |
| 02/20/2002 | CN1079390C Propynyl or dienyl diaromatic compounds |
| 02/20/2002 | CN1079282C Method for improving catalyst activity and catalyst produced thereby |
| 02/19/2002 | US6348627 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/19/2002 | US6348478 Biphenylamidine derivatives |
| 02/19/2002 | US6348468 Pyridazine compounds and compositions containing the same |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | CA2222204C Process for converting 2,4-dichloropyridines into 2-aryloxy-4-chloropyridines |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002012178A1 Compounds acting as melanocortin receptor ligands |
| 02/14/2002 | WO2002012165A1 (poly)ethereal ammonium salts of herbicides bearing acidic moieties and their use as herbicides |
| 02/14/2002 | WO2002011725A1 Inflammatory cytokine production inhibitors |
| 02/14/2002 | WO2002011724A2 Neuroprotective 2-pyridinamine compositions and related methods |
| 02/14/2002 | WO2002011707A2 Drugs for incontinence |
| 02/14/2002 | WO2001074910A3 Ether-amine based polymerization catalysts, compositions and processes using same |
| 02/14/2002 | WO2001070671A3 Insecticidal anthranilamides |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | WO2001044324A3 Polymerization of olefins |
| 02/14/2002 | US20020019569 Oxime compounds, their use, and intermediates for their production |
| 02/14/2002 | US20020019543 Thiol derivative, metallo-beta-lactamase inhibitors |